These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34565080)

  • 1. Dyslipidemia in pediatrician's practice.
    Burlutskaya AV; Tril VE; Polischuk LV; Pokrovskii VM
    Rev Cardiovasc Med; 2021 Sep; 22(3):817-834. PubMed ID: 34565080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis.
    Sunitha S; Rajappa M; Thappa DM; Chandrashekar L; Munisamy M; Revathy G; Priyadarssini M
    Indian J Dermatol Venereol Leprol; 2015; 81(5):464-71. PubMed ID: 26323680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Morrison CC; Dunn J; Nguyen M; Blasi PR; Whitlock EP
    JAMA; 2016 Aug; 316(6):634-44. PubMed ID: 27532918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2012 Oct; 11():125. PubMed ID: 23057687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
    Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
    J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern methods of diagnosis dyslipidemia ].
    Sukhorukov VN; Karagodin VP; Orekhov AN
    Patol Fiziol Eksp Ter; 2016; 60(1):65-72. PubMed ID: 29215251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia in rural areas of North China: prevalence, characteristics, and predictive value.
    Gao N; Yu Y; Zhang B; Yuan Z; Zhang H; Song Y; Zhao M; Ji J; Liu L; Xu C; Zhao J
    Lipids Health Dis; 2016 Sep; 15(1):154. PubMed ID: 27619340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid profile assessed in the family pediatrician's office: the COLIBRI'- SIMPeF study.
    Giussani M; Antolini L; De' Angelis M; Guardamagna O; Dozzi M; Genovesi S
    Eur J Pediatr; 2021 Jan; 180(1):147-156. PubMed ID: 32613309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature.
    Esfarjani SV; Zakerkish M
    J Family Med Prim Care; 2022 Dec; 11(12):7519-7526. PubMed ID: 36994010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and treatment of dyslipidemias in children and adolescents.
    Daniels SR
    Horm Res Paediatr; 2011; 76 Suppl 1():47-51. PubMed ID: 21778749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: International Childhood Cardiovascular Cohort Consortium.
    Koskinen J; Juonala M; Dwyer T; Venn A; Thomson R; Bazzano L; Berenson GS; Sabin MA; Burns TL; Viikari JSA; Woo JG; Urbina EM; Prineas R; Hutri-Kähönen N; Sinaiko A; Jacobs D; Steinberger J; Daniels S; Raitakari OT; Magnussen CG
    Circulation; 2018 Mar; 137(12):1246-1255. PubMed ID: 29170152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.
    Lechner K; McKenzie AL; Kränkel N; Von Schacky C; Worm N; Nixdorff U; Lechner B; Scherr J; Weingärtner O; Krauss RM
    Metab Syndr Relat Disord; 2020 May; 18(4):176-185. PubMed ID: 32119801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda.
    Kavishe B; Vanobberghen F; Katende D; Kapiga S; Munderi P; Baisley K; Biraro S; Mosha N; Mutungi G; Mghamba J; Hughes P; Smeeth L; Grosskurth H; Peck R
    PLoS One; 2019; 14(12):e0223189. PubMed ID: 31809516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and management of dyslipidemia in children and adolescents.
    Kwiterovich PO
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria.
    Olamoyegun MA; Oluyombo R; Asaolu SO
    Ann Afr Med; 2016; 15(4):194-199. PubMed ID: 27853034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.